Modern Surgical Management of Familial and Sporadic Parathyroid and Adrenal Disorders
Anouk Scholten
Modern Surgical Management of Familial and Sporadic Parathyroid and Adrenal Disorders – A. Scholten. Thesis, University Utrecht, Faculty of Medicine, The Netherlands
ISBN 978 94 6108 437 8 Printed by Gildeprint, The Netherlands Lay out Anouk Scholten & Gildeprint Cover Hennie Schrijver
Copyright No part of this thesis may be reproduced, stored in a database or retrieval system, or transmitted in any form of by any means without prior written permission of the author, or when appropriate, the publisher of the published papers.
The work in this thesis was supported by the Fulbright Center.
Finanical Support for this thesis was generously provided by Chirurgisch Fonds Universitair Medisch Centrum Utrecht, Genzyme Nederland, Ipsen Farmaceutica BV, Novartis Oncology, WHAM BV.
Modern Surgical Management of Familial and Sporadic Parathyroid and Adrenal Disorders
Moderne Chirurgische Behandeling van Familiale en Sporadische Aandoeningen van Bijschildklier en Bijnier
(met een samenvatting in het Nederlands)
ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. G.J. van der Zwaan, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 16 mei 2013 des middags 2.30 uur
door
Anouk Scholten
geboren op 30 oktober 1985 te Amersfoort
Promotor: Prof.dr. I.H.M. Borel Rinkes Co promotoren: Dr. M.R. Vriens Dr. G.D. Valk
aan mijn sterren
Contents
Chapter 1 General Introduction 8
Part I Parathyroid Glands
Chapter 2 Surgical Management of Primary Hyperparathyroidism in 26 Multiple Endocrine Neoplasia Type 1
Chapter 3 Surgical Management of Primary Hyperparathyroidism in 48 Multiple Endocrine Neoplasia Type 2A
Chapter 4 Surgical Management of Primary Hyperparathyroidism in 64 Sporadic versus Multiple Endocrine Neoplasia Patients
Chapter 5 Surgical Management of Primary Hyperparathyroidism, 80 Race and Intraoperative Parathyroid Hormone Measurement
Part II Adrenal Glands
Chapter 6 Laparoscopic Adrenalectomy, Surgical Outcome Analysis 96
Chapter 7 Laparoscopic Adrenalectomy, Variant Venous Anatomy 110
Chapter 8 Surgical Management of Pheochromocytoma Crisis 124
Chapter 9 Surgical Management of Pheochromocytoma in 158 Multiple Endocrine Neoplasia Type 2, Hemodynamic Instability
Chapter 10 Surgical Management of Pheochromocytoma in 172 Multiple Endocrine Neoplasia Type 2, Subtotal Adrenalectomy
Chapter 11 General Discussion and Future Perspectives 188
Chapter 12 Summary in Dutch 202
Chapter 13 Review Committee 212 Acknowledgements 216 Curriculum Vitae 224 List of publications 228
General Introduction
General Introduction
Surgical endocrinology or endocrine surgical oncology is an important component of general surgery. As reported in Richard Welbourne’s book History of Endocrine Surgery, the term “endocrine” is from the Greek endo, meaning “within”, and kipiveiv, meaning “separate”, documenting the relationship of endocrine surgery and general surgery. Endocrine glands and tumors often make and secrete hormones; “hormone” is a term derived from the Greek word “to excite”.1 Examples of such glands are the thyroid gland, the parathyroid glands, the pancreatic gland, and the adrenal glands. Endocrine tumors of these glands can occur sporadically or develop as part of familial syndromes. The most common familial syndromes known to cause endocrine tumors are multiple endocrine neoplasia (MEN) syndromes type 1 and 2.
Multiple Endocrine Neoplasia Multiple endocrine neoplasia type 1 (MEN1) was first recognized in 1903 by Erdheim, and further described as ‘endocrine adenomatosis’ by Wermer in 1954.2 MEN1 is a rare autosomal dominant inherited disorder caused by a germline mutation in the MEN1 gene on chromosome 11. The prevalence is estimated to be two to three per hundred thousand.3 Patients with MEN1 are prone to developing primary hyperparathyroidism (pHPT), pancreatic endocrine tumors, and pituitary adenomas. Other less frequent manifestations are adrenocortical adenomas and neuroendocrine tumors of the stomach, thymus, and bronchus.4 Multiple endocrine neoplasia type 2 (MEN2) was initially introduced in 1961, as Sipple’s syndrome, in a patient with bilateral pheochromocytoma, thyroid cancer and parathyroid enlargement. In 1968, Steiner further described this syndrome as MEN2, a similar but separate entity from MEN1. Later, Williams divided MEN2 into two distinct clinical syndromes: MEN2A and MEN2B.5 Both are autosomal dominant inherited disorders caused by mutations in the RET proto oncogene on chromosome 10.6 Virtually all patients with MEN2A develop medullary thyroid carcinoma. Therefore, affected patients should undergo prophylactic total thyroidectomy according to their RET proto oncogene mutation as recommended by current guidelines. Half of MEN2A patients develop pheochromocytomas, and 20% to 30% develop pHPT in the course of the disease.5 MEN2B is more aggressive and less prevalent compared with MEN2A. It is associated with medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, intenstinal ganglioneuromas, and a marfanoid habitus.7
This thesis provides up to date information on the management of patients with familial and sporadic endocrine tumors of the parathyroid gland and the adrenal gland.